These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 1746574)

  • 21. Sterility testing of cell therapy products: parallel comparison of automated methods with a CFR-compliant method.
    Khuu HM; Patel N; Carter CS; Murray PR; Read EJ
    Transfusion; 2006 Dec; 46(12):2071-82. PubMed ID: 17176318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of an aseptic technique testing and challenge kit (ATTACK).
    Turco S; Miele WH; Barnoski D
    Hosp Pharm; 1993 Jan; 28(1):11-3, 16-8. PubMed ID: 10124004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quality-control plan for intravenous admixture programs. I: Visual inspection of solutions and environmental testing.
    Morris BG; Avis KE
    Am J Hosp Pharm; 1980 Feb; 37(2):189-95. PubMed ID: 7361790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upgrading quality assurance for pharmacy-prepared sterile products.
    Zellmer WA
    Am J Hosp Pharm; 1991 Nov; 48(11):2387-8. PubMed ID: 1746571
    [No Abstract]   [Full Text] [Related]  

  • 25. Laboratory considerations of United States Pharmacopeia Chapter <71> sterility tests and its application to pharmaceutical compounding.
    Hyde TD
    Int J Pharm Compd; 2014; 18(1):46-52. PubMed ID: 24881341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Validation of aseptic technique of parenteral nutrition compounding in a pharmacy service according to USP Chapter 797].
    Romero Jiménez RM; Pernía López MS; Sánchez Fresneda MN; Sanjurjo Sáez M
    Nutr Hosp; 2013; 28(5):1494-7. PubMed ID: 24160206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nitroglycerin injection manufactured by a hospital pharmacy.
    Clarke AJ; Watkins RE
    Am J Hosp Pharm; 1985 Jul; 42(7):1542-6. PubMed ID: 3927720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recommended guidelines for quality assurance in hospital centralized intravenous admixture services. National Coordinating Committee on Large Volume Parenterals.
    Am J Hosp Pharm; 1980 May; 37(5):645-55. PubMed ID: 7386471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sterility Testing of Injectable Products: Evaluation of the Growth-based BacT/ALERT® 3D™ Dual T Culture System.
    Kaiser SJ; Mutters NT; Backhaus J; Frank U; Günther F
    PDA J Pharm Sci Technol; 2016 11/12; 70(6):568-576. PubMed ID: 27325593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Draft guidelines on compounding of nonsterile products in pharmacies. American Society of Hospital Pharmacists.
    Am J Hosp Pharm; 1993 Jul; 50(7):1452-61. PubMed ID: 8362883
    [No Abstract]   [Full Text] [Related]  

  • 31. An in vitro analysis of microbial transmission during EUS-guided FNA and the utility of sterilization agents.
    Sing J; Erickson R; Fader R
    Gastrointest Endosc; 2006 Nov; 64(5):774-9. PubMed ID: 17055873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microbial growth tests in anti-neoplastic injectable solutions.
    Paris I; Paci A; Rey JB; Bourget P
    J Oncol Pharm Pract; 2005 Mar; 11(1):7-12. PubMed ID: 16460598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of two work practice changes on the microbial contamination rates of pharmacy-compounded sterile preparations.
    Trissel LA; Gentempo JA; Saenz LM; Woodard MY; Angeles CH
    Am J Health Syst Pharm; 2007 Apr; 64(8):837-41. PubMed ID: 17420200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "Absolute" sterility and "absolute" freedom from particle contamination.
    Knapp JZ
    PDA J Pharm Sci Technol; 1998; 52(4):173-81. PubMed ID: 9752713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microbial contamination potential of solutions in prefilled disposable syringes used with a syringe pump.
    Mitrano FP; Baptista RJ; Newton DW; Augustine SC
    Am J Hosp Pharm; 1986 Jan; 43(1):78-80. PubMed ID: 3953587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of the BacT/ALERTR 3D system for sterility testing of injectable products.
    Bugno A; Lira RS; Oliveira WA; Almodovar AA; Saes DP; Pinto Tde J
    Braz J Microbiol; 2015; 46(3):743-7. PubMed ID: 26413055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Method for testing aseptic technique of intravenous admixture personnel.
    Dirks I; Smith FM; Furtado D; White SJ; Godwin HN
    Am J Hosp Pharm; 1982 Mar; 39(3):457-9. PubMed ID: 7041641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aseptic simulation test for cytotoxic drug production in isolators.
    Savry A; Correard F; Bennis Y; Roubaud S; Gauthier-Villano L; Pisano P; Pourroy B
    Am J Health Syst Pharm; 2014 Mar; 71(6):476-81. PubMed ID: 24589539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Basics of sterile compounding: aseptic processing.
    Akers MJ
    Int J Pharm Compd; 2015; 19(1):49-56. PubMed ID: 25902628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Draft guidance for industry; container and closure integrity testing in lieu of sterility testing as a component of the stability protocol for sterile products; availability--FDA. Notice.
    Fed Regist; 1998 Jan; 63(18):4272-3. PubMed ID: 10177326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.